This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Samuel John: Innovator in Cancer Treatment
Introduction
Samuel John is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Samuel John holds a patent titled "Targeting LILRB4 with CAR-T or CAR-NK Cells in the Treatment of Cancer." This patent represents his commitment to advancing therapeutic options for cancer patients. He has 1 patent to his name, showcasing his dedication to innovation in medical science.
Career Highlights
Samuel John is affiliated with the University of Texas System, where he works on groundbreaking research in cancer therapies. His work focuses on utilizing CAR-T and CAR-NK cell technologies to improve treatment outcomes for patients suffering from various forms of cancer.
Collaborations
Samuel collaborates with esteemed colleagues, including Chengcheng Zhang and Heyu Chen. Their combined expertise enhances the research efforts at the University of Texas System, contributing to advancements in cancer treatment.
Conclusion
Samuel John's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions are paving the way for new therapeutic strategies that could benefit countless patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile